The type 2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced insulin release following an oral glucose load

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

The type 2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced insulin release following an oral glucose load. / Holmkvist, Johan; Banasik, Karina; Andersen, Gitte; Unoki, Hiroyuki; Jensen, Thomas Skot; Pisinger, Charlotta; Borch-Johnsen, Knut; Sandbaek, Annelli; Lauritzen, Torsten; Brunak, Sören; Maeda, Shiro; Hansen, Torben; Pedersen, Oluf.

In: PLoS ONE, Vol. 4, No. 6, 2009, p. e5872.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Holmkvist, J, Banasik, K, Andersen, G, Unoki, H, Jensen, TS, Pisinger, C, Borch-Johnsen, K, Sandbaek, A, Lauritzen, T, Brunak, S, Maeda, S, Hansen, T & Pedersen, O 2009, 'The type 2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced insulin release following an oral glucose load', PLoS ONE, vol. 4, no. 6, pp. e5872. https://doi.org/10.1371/journal.pone.0005872

APA

Holmkvist, J., Banasik, K., Andersen, G., Unoki, H., Jensen, T. S., Pisinger, C., Borch-Johnsen, K., Sandbaek, A., Lauritzen, T., Brunak, S., Maeda, S., Hansen, T., & Pedersen, O. (2009). The type 2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced insulin release following an oral glucose load. PLoS ONE, 4(6), e5872. https://doi.org/10.1371/journal.pone.0005872

Vancouver

Holmkvist J, Banasik K, Andersen G, Unoki H, Jensen TS, Pisinger C et al. The type 2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced insulin release following an oral glucose load. PLoS ONE. 2009;4(6):e5872. https://doi.org/10.1371/journal.pone.0005872

Author

Holmkvist, Johan ; Banasik, Karina ; Andersen, Gitte ; Unoki, Hiroyuki ; Jensen, Thomas Skot ; Pisinger, Charlotta ; Borch-Johnsen, Knut ; Sandbaek, Annelli ; Lauritzen, Torsten ; Brunak, Sören ; Maeda, Shiro ; Hansen, Torben ; Pedersen, Oluf. / The type 2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced insulin release following an oral glucose load. In: PLoS ONE. 2009 ; Vol. 4, No. 6. pp. e5872.

Bibtex

@article{29e93bc071f911de8bc9000ea68e967b,
title = "The type 2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced insulin release following an oral glucose load",
abstract = "BACKGROUND: Polymorphisms in the potassium channel, voltage-gated, KQT-like subfamily, member 1 (KCNQ1) have recently been reported to associate with type 2 diabetes. The primary aim of the present study was to investigate the putative impact of these KCNQ1 polymorphisms (rs2283228, rs2237892, rs2237895, and rs2237897) on estimates of glucose stimulated insulin release. METHODOLOGY/PRINCIPAL FINDINGS: Genotypes were examined for associations with serum insulin levels following an oral glucose tolerance test (OGTT) in a population-based sample of 6,039 middle-aged and treatment-na{\"i}ve individuals. Insulin release indices estimated from the OGTT and the interplay between insulin sensitivity and insulin release were investigated using linear regression and Hotelling T2 analyses. Applying an additive genetic model the minor C-allele of rs2237895 was associated with reduced serum insulin levels 30 min (mean+/-SD: (CC) 277+/-160 vs. (AC) 280+/-164 vs. (AA) 299+/-200 pmol/l, p = 0.008) after an oral glucose load, insulinogenic index (29.6+/-17.4 vs. 30.2+/-18.7vs. 32.2+/-22.1, p = 0.007), incremental area under the insulin curve (20,477+/-12,491 vs. 20,503+/-12,386 vs. 21,810+/-14,685, p = 0.02) among the 4,568 individuals who were glucose tolerant. Adjustment for the degree of insulin sensitivity had no effect on the measures of reduced insulin release. The rs2237895 genotype had a similar impact in the total sample of treatment-na{\"i}ve individuals. No association with measures of insulin release were identified for the less common diabetes risk alleles of rs2237892, rs2237897, or rs2283228. CONCLUSION: The minor C-allele of rs2237895 of KCNQ1, which has a prevalence of about 42% among Caucasians was associated with reduced measures of insulin release following an oral glucose load suggesting that the increased risk of type 2 diabetes, previously reported for this variant, likely is mediated through an impaired beta cell function.",
author = "Johan Holmkvist and Karina Banasik and Gitte Andersen and Hiroyuki Unoki and Jensen, {Thomas Skot} and Charlotta Pisinger and Knut Borch-Johnsen and Annelli Sandbaek and Torsten Lauritzen and S{\"o}ren Brunak and Shiro Maeda and Torben Hansen and Oluf Pedersen",
note = "Export Date: 4 November 2009Source: ScopusArt. No.: 41",
year = "2009",
doi = "10.1371/journal.pone.0005872",
language = "English",
volume = "4",
pages = "e5872",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "6",

}

RIS

TY - JOUR

T1 - The type 2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced insulin release following an oral glucose load

AU - Holmkvist, Johan

AU - Banasik, Karina

AU - Andersen, Gitte

AU - Unoki, Hiroyuki

AU - Jensen, Thomas Skot

AU - Pisinger, Charlotta

AU - Borch-Johnsen, Knut

AU - Sandbaek, Annelli

AU - Lauritzen, Torsten

AU - Brunak, Sören

AU - Maeda, Shiro

AU - Hansen, Torben

AU - Pedersen, Oluf

N1 - Export Date: 4 November 2009Source: ScopusArt. No.: 41

PY - 2009

Y1 - 2009

N2 - BACKGROUND: Polymorphisms in the potassium channel, voltage-gated, KQT-like subfamily, member 1 (KCNQ1) have recently been reported to associate with type 2 diabetes. The primary aim of the present study was to investigate the putative impact of these KCNQ1 polymorphisms (rs2283228, rs2237892, rs2237895, and rs2237897) on estimates of glucose stimulated insulin release. METHODOLOGY/PRINCIPAL FINDINGS: Genotypes were examined for associations with serum insulin levels following an oral glucose tolerance test (OGTT) in a population-based sample of 6,039 middle-aged and treatment-naïve individuals. Insulin release indices estimated from the OGTT and the interplay between insulin sensitivity and insulin release were investigated using linear regression and Hotelling T2 analyses. Applying an additive genetic model the minor C-allele of rs2237895 was associated with reduced serum insulin levels 30 min (mean+/-SD: (CC) 277+/-160 vs. (AC) 280+/-164 vs. (AA) 299+/-200 pmol/l, p = 0.008) after an oral glucose load, insulinogenic index (29.6+/-17.4 vs. 30.2+/-18.7vs. 32.2+/-22.1, p = 0.007), incremental area under the insulin curve (20,477+/-12,491 vs. 20,503+/-12,386 vs. 21,810+/-14,685, p = 0.02) among the 4,568 individuals who were glucose tolerant. Adjustment for the degree of insulin sensitivity had no effect on the measures of reduced insulin release. The rs2237895 genotype had a similar impact in the total sample of treatment-naïve individuals. No association with measures of insulin release were identified for the less common diabetes risk alleles of rs2237892, rs2237897, or rs2283228. CONCLUSION: The minor C-allele of rs2237895 of KCNQ1, which has a prevalence of about 42% among Caucasians was associated with reduced measures of insulin release following an oral glucose load suggesting that the increased risk of type 2 diabetes, previously reported for this variant, likely is mediated through an impaired beta cell function.

AB - BACKGROUND: Polymorphisms in the potassium channel, voltage-gated, KQT-like subfamily, member 1 (KCNQ1) have recently been reported to associate with type 2 diabetes. The primary aim of the present study was to investigate the putative impact of these KCNQ1 polymorphisms (rs2283228, rs2237892, rs2237895, and rs2237897) on estimates of glucose stimulated insulin release. METHODOLOGY/PRINCIPAL FINDINGS: Genotypes were examined for associations with serum insulin levels following an oral glucose tolerance test (OGTT) in a population-based sample of 6,039 middle-aged and treatment-naïve individuals. Insulin release indices estimated from the OGTT and the interplay between insulin sensitivity and insulin release were investigated using linear regression and Hotelling T2 analyses. Applying an additive genetic model the minor C-allele of rs2237895 was associated with reduced serum insulin levels 30 min (mean+/-SD: (CC) 277+/-160 vs. (AC) 280+/-164 vs. (AA) 299+/-200 pmol/l, p = 0.008) after an oral glucose load, insulinogenic index (29.6+/-17.4 vs. 30.2+/-18.7vs. 32.2+/-22.1, p = 0.007), incremental area under the insulin curve (20,477+/-12,491 vs. 20,503+/-12,386 vs. 21,810+/-14,685, p = 0.02) among the 4,568 individuals who were glucose tolerant. Adjustment for the degree of insulin sensitivity had no effect on the measures of reduced insulin release. The rs2237895 genotype had a similar impact in the total sample of treatment-naïve individuals. No association with measures of insulin release were identified for the less common diabetes risk alleles of rs2237892, rs2237897, or rs2283228. CONCLUSION: The minor C-allele of rs2237895 of KCNQ1, which has a prevalence of about 42% among Caucasians was associated with reduced measures of insulin release following an oral glucose load suggesting that the increased risk of type 2 diabetes, previously reported for this variant, likely is mediated through an impaired beta cell function.

U2 - 10.1371/journal.pone.0005872

DO - 10.1371/journal.pone.0005872

M3 - Journal article

C2 - 19516902

VL - 4

SP - e5872

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 6

ER -

ID: 13206284